Bio-Rad Laboratories, Inc. (BIO) News
Follow Bio-Rad Laboratories, Inc. (BIO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Weekly Recap: Bio-Rad growth and margin plan and digital PCR expansion
Bio-Rad Laboratories, Inc. Class A (NYSE:BIO) unveiled a multi-year plan to drive growth, margin expansion and stronger free cash flow by leveraging its digital PCR franchise—led by Droplet Digital PCR, a large assay lib
NEWS | Sep 28, 2026, 11:04 AM UTC
L
Bioton Q2 Net Loss At 9.2 Million Zlotys
Bioton SA GPW:BIO
EARNINGS | Sep 15, 2026, 03:28 PM UTC
L
BIO: FY26 delivered record revenue, profit, and margin, with global expansion and new China entry ahead
Record FY26 results saw revenue rise 30% to $23.9m, with strong profit growth and gross margin of 62.1%. Distribution expanded to 7,500 points of sale, international markets contributed $1.8m, and onshore manufacturing p
EARNINGS | Sep 14, 2026, 11:54 PM UTC
L
BIO: Digital PCR growth, operational efficiency, and R&D focus drive long-term margin expansion
Q2 saw sequential improvement, with digital PCR and APAC strength offsetting softness in A&G and China. Guidance anticipates flat Q3 and a modest Q4 ramp, driven by quality controls and blood typing. Operational efficien
EARNINGS | Sep 09, 2026, 08:54 PM UTC
L
Biome Australia to launch larger-format Daily Probiotic 60 lines
Biome Australia Group (ASX:BIO) announced the imminent launch of Biome Daily Probiotic 60 and Biome Daily Kids Probiotic 60 for gastrointestinal symptoms and antibiotic side effects, plus winter immune support.
EQUITY | Sep 09, 2026, 03:26 AM UTC
M
Biome Australia enters China probiotics market via exclusive H&S Global deal
Biome Australia enters China’s probiotics market through an exclusive H&S Global deal, TradingView News reports.
GEOPOLITICS | Aug 27, 2026, 05:06 AM UTC
L
Biome Australia To Launch In China
Biome Australia To Launch In China
GEOPOLITICS | Aug 27, 2026, 01:29 AM UTC
L
Bio-Rad Laboratories Lowers FY2026 Sales Guidance of $2.506B-$2.596B vs $2.567B Est
Bio-Rad Laboratories (NYSE: BIO ) lowers FY2026 sales outlook from $2.506 billion-$2.596 billion to $2.506 billion-$2.596 billion vs $2.567 billion estimate.
EARNINGS | Aug 04, 2026, 08:24 PM UTC
L
BIO Meets US Officials
BIO's board spoke with US national security and health officials regarding China, according to the CEO.
EQUITY | Jun 23, 2026, 06:20 PM UTC